FOX
33
3
KEY
55
8
NSC
60
-7
CPB
55
8
PX
52
2
EBAY
50
-2
AAP
23
3
DAL
61
3
BBY
58
5
F
43
3
BF.B
59
2
CCL
68
3
NUE
47
3
VZ
54
4
NFLX
59
2
VRSK
56
16
QRVO
56
4
CAG
37
3
GOOG
53
2
SPG
53
2
FOX
33
3
KEY
55
8
NSC
60
-7
CPB
55
8
PX
52
2
EBAY
50
-2
AAP
23
3
DAL
61
3
BBY
58
5
F
43
3
BF.B
59
2
CCL
68
3
NUE
47
3
VZ
54
4
NFLX
59
2
VRSK
56
16
QRVO
56
4
CAG
37
3
GOOG
53
2
SPG
53
2
Financhill
Back

Tandem Diabetes Care Stock Predictions

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

TNDM
Tandem Diabetes Care

Last Price:
43.96
Seasonality Move:
-20.38%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Tandem Diabetes Care Stock Forecast

  • Over the next 52 weeks, Tandem Diabetes Care has on average historically risen by 66% based on the past 10 years of stock performance.
  • Tandem Diabetes Care has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Tandem Diabetes Care Stock Undervalued?
    The current Tandem Diabetes Care [TNDM] share price is $43.97. The Score for TNDM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • TNDM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Tandem Diabetes Care Stock Go Up Next Year?

  • Over the next 52 weeks, Tandem Diabetes Care has on average historically risen by 66% based on the past 10 years of stock performance.

Tandem Diabetes Care Stock Rating

Sell
47
Tandem Diabetes Care (TNDM) is a Sell

Is Tandem Diabetes Care overpriced?

  • Tandem Diabetes Care has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Tandem Diabetes Care Stock Price History

Is TNDM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
tandemdiabetes.com

52-Week Data

52-Week High:
53.69
52-Week Low:
13.82

Prediction Charts

Market Cap:
2.88B
Price in USD:
43.97
Volume:
994.81K
Beta:
1.01

Technical Analysis

SMA50:
42.26
SMA100:
43.31
SMA200:
35.41
52-Wk Change:
84.9%

Stock Predictions

  • Is Tandem Diabetes Care stock public?
    Yes, Tandem Diabetes Care is a publicly traded company.
  • What is the Tandem Diabetes Care stock quote today?
    The Tandem Diabetes Care stock price is 43.97 USD today.
  • How to buy Tandem Diabetes Care stock online?
    You can buy Tandem Diabetes Care shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-26 44.81 44.33 45.58 43.92
Aug-27 43.85 45.57 46.15 43.85
Aug-28 45.25 44.38 45.62 44.21
Aug-29 45.00 44.20 45.79 43.62
Aug-30 44.78 43.50 45.95 42.83
Sep-3 42.98 41.77 43.42 41.51
Sep-4 41.75 41.12 42.05 40.86
Sep-5 41.12 42.77 44.09 40.50
Sep-6 42.85 42.43 43.46 41.13
Sep-9 43.29 42.24 43.66 41.90
Sep-10 42.25 41.00 42.49 39.58
Sep-11 40.70 42.74 43.09 40.04
Sep-12 42.75 43.76 45.10 42.75
Sep-13 44.01 43.97 45.40 43.76

Tandem Diabetes Care Earnings

Tandem Diabetes Care Earnings Report: Per Share Tandem Diabetes Care Earnings Q1 Q2 Q3 and Q4 last year and next year.

Tandem Diabetes Care Forecast Revenue Growth

Tandem Diabetes Care Stock Analysis: Historical quarterly revenues per share for Tandem Diabetes Care and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.13 per share, an increase this year of $0.08 per share, and an increase next year of $0.55 per share.

* Tandem Diabetes Care stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.